Extensive Sub-RPE Complement Deposition in a Nonhuman Primate Model of Early-Stage Diabetic Retinopathy.

Shuxin Fan, Ziqi Yang, Yan Liu, Jiawei Zhong, Shuyao Zhang, Yuhua Xiao, Xu Liu, Wei Yi, Chang He, Youjin Hu, Xialin Liu
Author Information
  1. Shuxin Fan: State Key Laboratory of Ophthalmology, Zhongshan Ophthalmic Center, Sun Yat-sen University, Guangzhou, China.
  2. Ziqi Yang: State Key Laboratory of Ophthalmology, Zhongshan Ophthalmic Center, Sun Yat-sen University, Guangzhou, China.
  3. Yan Liu: State Key Laboratory of Ophthalmology, Zhongshan Ophthalmic Center, Sun Yat-sen University, Guangzhou, China.
  4. Jiawei Zhong: State Key Laboratory of Ophthalmology, Zhongshan Ophthalmic Center, Sun Yat-sen University, Guangzhou, China.
  5. Shuyao Zhang: State Key Laboratory of Ophthalmology, Zhongshan Ophthalmic Center, Sun Yat-sen University, Guangzhou, China.
  6. Yuhua Xiao: State Key Laboratory of Ophthalmology, Zhongshan Ophthalmic Center, Sun Yat-sen University, Guangzhou, China.
  7. Xu Liu: State Key Laboratory of Ophthalmology, Zhongshan Ophthalmic Center, Sun Yat-sen University, Guangzhou, China.
  8. Wei Yi: State Key Laboratory of Ophthalmology, Zhongshan Ophthalmic Center, Sun Yat-sen University, Guangzhou, China.
  9. Chang He: State Key Laboratory of Ophthalmology, Zhongshan Ophthalmic Center, Sun Yat-sen University, Guangzhou, China.
  10. Youjin Hu: State Key Laboratory of Ophthalmology, Zhongshan Ophthalmic Center, Sun Yat-sen University, Guangzhou, China.
  11. Xialin Liu: State Key Laboratory of Ophthalmology, Zhongshan Ophthalmic Center, Sun Yat-sen University, Guangzhou, China.

Abstract

Purpose: This study aims to reveal retinal abnormities in a spontaneous diabetic nonhuman primate model and explore the mechanism of featured injuries.
Methods: Twenty-eight cynomolgus monkeys were identified to suffer from spontaneous type 2 diabetes from a colony of more than eight-hundred aged monkeys, and twenty-six age-matched ones were chosen as controls. Their blood biochemistry profiles were determined and retinal changes were examined by multimodal imaging, hematoxylin and eosin staining, and immunofluorescence. Retinal pigment epithelium (RPE) cells were further investigated by RNA sequencing and computational analyses.
Results: These diabetic monkeys were characterized by early retinal vascular and neural damage and dyslipidemia. The typical acellular capillaries and pericyte ghost were found in the diabetic retina, which also exhibited reduced retinal nerve fiber layer thickness compared to controls (all P < 0.05). Of note, distinct sub-RPE drusenoid lesions were extensively observed in these diabetic monkeys (46.43% vs. 7.69%), and complements including C3 and C5b-9 were deposited in these lesions. RNA-seq analysis revealed complement activation, AGE/RAGE activation and inflammatory response in diabetic RPE cells. Consistently, the plasma C3 and C4 were particularly increased in the diabetic monkeys with drusenoid lesions (P = 0.028 and 0.029).
Conclusions: The spontaneous type 2 diabetic monkeys featured with early-stage retinopathy including not only typical vascular and neural damage but also a distinct sub-RPE deposition. The complement activation of RPE cells in response to hyperglycemia might contribute to the deposition, revealing an unrecognized role of RPE cells in the early-stage pathological process of diabetic retinopathy.

References

  1. Ophthalmology. 2002 Oct;109(10):1767-79 [PMID: 12359593]
  2. Retina. 2013 May;33(5):911-9 [PMID: 23407352]
  3. Diabetes. 2015 Jul;64(7):2603-8 [PMID: 25732190]
  4. Ophthalmology. 2003 Sep;110(9):1677-82 [PMID: 13129861]
  5. Br J Ophthalmol. 2009 Aug;93(8):1037-41 [PMID: 19429584]
  6. Arch Ophthalmol. 2003 May;121(5):658-63 [PMID: 12742843]
  7. Br J Ophthalmol. 1995 Aug;79(8):728-31 [PMID: 7547782]
  8. Arch Ophthalmol. 1997 Feb;115(2):267-73 [PMID: 9046265]
  9. J Vis Exp. 2013 Jun 13;(76):e50489 [PMID: 23793268]
  10. Diabetologia. 1974 Nov;10 Suppl:671-7 [PMID: 4615028]
  11. FASEB J. 2005 Oct;19(12):1683-5 [PMID: 16099945]
  12. Acta Ophthalmol Scand. 2007 Sep;85(6):613-7 [PMID: 17408388]
  13. Graefes Arch Clin Exp Ophthalmol. 2019 Mar;257(3):455-463 [PMID: 30684011]
  14. Diabetes. 2002 Dec;51(12):3499-504 [PMID: 12453906]
  15. Arch Ophthalmol. 2011 Feb;129(2):196-9 [PMID: 21320966]
  16. J Diabetes Complications. 2008 Jul-Aug;22(4):284-94 [PMID: 18413184]
  17. Prog Retin Eye Res. 2013 May;34:19-48 [PMID: 23416119]
  18. Proc Natl Acad Sci U S A. 2006 Feb 14;103(7):2328-33 [PMID: 16452172]
  19. Diabetes Care. 2017 Mar;40(3):412-418 [PMID: 28223445]
  20. Exp Eye Res. 2005 Jan;80(1):37-42 [PMID: 15652524]
  21. Am J Pathol. 1989 Feb;134(2):231-5 [PMID: 2916645]
  22. Cell. 2019 Feb 21;176(5):1222-1237.e22 [PMID: 30712875]
  23. Diabetes Care. 2018 Oct;41(10):2202-2211 [PMID: 30061321]
  24. Diabetologia. 2007 Jun;50(6):1294-303 [PMID: 17380318]
  25. Diabetologia. 2008 Jun;51(6):1051-61 [PMID: 18414830]
  26. Arch Ophthalmol. 1996 Sep;114(9):1079-84 [PMID: 8790092]
  27. ILAR J. 2006;47(3):186-98 [PMID: 16804194]
  28. Cell Rep. 2019 Nov 26;29(9):2835-2848.e4 [PMID: 31775049]
  29. Graefes Arch Clin Exp Ophthalmol. 1996 Jun;234(6):388-98 [PMID: 8738706]
  30. Diabetes. 2005 May;54(5):1534-42 [PMID: 15855343]
  31. Am J Ophthalmol. 2002 Sep;134(3):411-31 [PMID: 12208254]
  32. Diabetologia. 2010 Mar;53(3):572-83 [PMID: 20091023]
  33. Invest Ophthalmol Vis Sci. 2004 Dec;45(12):4543-53 [PMID: 15557466]
  34. Dis Model Mech. 2012 Jul;5(4):444-56 [PMID: 22730475]
  35. Ophthalmology. 1984 May;91(5):513-21 [PMID: 6204261]

MeSH Term

Animals
Complement Activation
Complement C3
Complement Membrane Attack Complex
Diabetes Mellitus, Type 2
Diabetic Retinopathy
Disease Models, Animal
Dyslipidemias
Hyperglycemia
Macaca fascicularis
Multimodal Imaging
Retinal Drusen
Retinal Pigment Epithelium
Retinal Vessels

Chemicals

Complement C3
Complement Membrane Attack Complex
SC5b-9 protein complex